readthroughSign in
CompanyCOGTNasdaqWaltham, MA

Cogent Biosciences, Inc.

Cogent Biosciences develops selective tyrosine kinase inhibitors for genetically defined diseases.

8-KNov 10Latest SEC filing
Nov 5Latest story